Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling

Maria Peiris-Pagès; Gloria Bonuccelli; Federica Sotgia; Michael P. Lisanti

doi:10.18632/oncotarget.24285

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling

Maria Peiris-Pagès, Gloria Bonuccelli, Federica Sotgia _ and Michael P. Lisanti

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:13254-13275. https://doi.org/10.18632/oncotarget.24285

Metrics: PDF 2210 views | HTML 4357 views | ?

Abstract

Maria Peiris-Pagès1,3, Gloria Bonuccelli2,3, Federica Sotgia2,3 and Michael P. Lisanti2,3

1Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK

2Translational Medicine, School of Environment and Life Sciences, Biomedical Research Centre (BRC), University of Salford, Greater Manchester, UK

3The Paterson Institute, University of Manchester, Withington, UK

Correspondence to:

Federica Sotgia, email: [email protected]

Michael P. Lisanti, email: [email protected]

Keywords: mitochondrial fission; OXPHOS; cancer stem-like cells (CSCs); cell migration; metastasis

Received: December 12, 2017 Accepted: January 09, 2018 Published: January 19, 2018

ABSTRACT

Mitochondria are dynamic organelles frequently undergoing fission and fusion events to maintain their integrity, bioenergetics and spatial distribution, which is fundamental to the processes of cell survival. Disruption in mitochondrial dynamics plays a role in cancer. Therefore, proteins involved in regulating mitochondrial dynamics are potential targets for treatment. mDIVI1 is an inhibitor of the mitochondrial fission protein DRP1, which induces i) mitochondrial oxidative stress and ii) effectively reduces mitochondrial metabolism. We show here that mDIVI1 is able to inhibit 3D tumorsphere forming capacity, cell migration and stemness-related signalling in breast cancer cells, indicating that mDIVI1 can potentially be used for the therapeutic elimination of cancer stem cells (CSCs).

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24285

Publication Alerts

Research Papers:

Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling

Abstract